Clinical Trials Browser

Phase 1 × ilorasertib × Tumor-Agnostic × Clear all

NCT02540876 2019-04-22

Ilorasertib in Treating Patients With CDKN2A-deficient Advanced or Metastatic Solid Cancers That Cannot Be Removed by Surgery

Phase 1 Completed

Neoplasm Metastasis